Taysha Gene Therapies Inc banner

Wall St Price Targets

TSHA Price Forecast
Based on 15 analysts

+180% Upside
from $4.37 today

Taysha Gene Therapies Inc (TSHA)’s 12-month stock price forecast through November 2027 has a consensus target of $12.24, implying 180% upside. The forecast is based on price targets from 15 Wall Street analysts.

TSHA Analyst Rating
Based on 13 analysts

avg. 4.77 of 5
Strong buy
10 77%
Buy
3 23%
Hold
0 0%
Sell
0 0%
Strong sell
0 0%

Analysts rate TSHA Strong buy, with 13 of 13 recommending Buy or Strong buy.

Taysha Gene Therapies Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is TSHA's stock price target?
Price Target
12.24 USD

According to Wall Street analysts, the average 1-year price target for TSHA is 12.24 USD with a low forecast of 9.09 USD and a high forecast of 19.95 USD.

What is the Revenue forecast for Taysha Gene Therapies Inc?
Projected CAGR
95%

The compound annual growth rate for Revenue over the next 8 years is 95%.

Back to Top